KCM
HARP

Kennedy Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Kennedy Capital Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-52,160
Closed -$593K – 785
2023
Q4 		$593K Sell
52,160
-827
-2% -$6.5K 0.01% 628
2023
Q3 		$214K Sell
52,987
-6
-0% -$44 0.01% 653
2023
Q2 		$376K Hold
52,993
– – 0.01% 619
2023
Q1 		$394K Buy
52,993
+36,844
+228% +$310K 0.01% 576
2022
Q4 		$117K Sell
16,149
-12,839
-44% -$108K ﹤0.01% 607
2022
Q3 		$281K Buy
28,988
+17,860
+160% +$333K 0.01% 579
2022
Q2 		$213K Sell
11,128
-107
-1% -$2.77K 0.01% 586
2022
Q1 		$558K Sell
11,235
-1,742
-13% -$90.3K 0.01% 549
2021
Q4 		$980K Buy
+12,977
New +$886K 0.02% 519

Kennedy Capital Management's HARP Position: Q1 2024 in Review

Kennedy Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 52,160 shares — an estimated $593K sold.

Kennedy Capital Management first reported a position in HARP in Q4 2021 and held it in 9 quarters. The position peaked at $980K in Q4 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

  • Kennedy Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 52,160 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $593K.
  • Kennedy Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Kennedy Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $980K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Kennedy Capital Management's 13F filing for Q1 2024, filed 15 May 2024.